1
|
Smits JP, Veldkamp MW and Wilde AA:
Mechanisms of inherited cardiac conduction disease. Europace.
7:122–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kawaguchi T, Hayashi H, Miyamoto A,
Yoshino T, Taniguchi A, Naiki N, Sugimoto Y, Ito M, Xue JQ,
Murakami Y and Horie M: Prognostic implications of progressive
cardiac conduction disease. Circ J. 77:60–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
den Hoed M, Eijgelsheim M, Esko T, Brundel
BJ, Peal DS, Evans DM, Nolte IM, Segrè AV, Holm H, Handsaker RE, et
al: Identification of heart rate-associated loci and their effects
on cardiac conduction and rhythm disorders. Nat Genet. 45:621–631.
2013. View
Article : Google Scholar : PubMed/NCBI
|
4
|
Beltran-Alvarez P, Tarradas A, Chiva C,
Pérez-Serra A, Batlle M, Pérez-Villa F, Schulte U, Sabidó E,
Brugada R, Pagans S, et al: Identification of N-terminal protein
acetylation and arginine methylation of the voltage-gated sodium
channel in end-stage heart failure human heart. J Mol Cell Cardiol.
76:126–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Xiong Q, Cao L, Hu J, Marian AJ and Hong
K: A rare loss-of-function SCN5A variant is associated with
lidocaine-induced ventricular fibrillation. Pharmacogenomics J.
14:372–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Li RG, Wang Q, Xu YJ, Zhang M, Qu XK, Liu
X, Fang WY and Yang YQ: Mutations of the SCN4B-encoded sodium
channel β4 subunit in familial atrial fibrillation. Int J Mol Med.
32:144–150. 2013.PubMed/NCBI
|
7
|
Riuró H, Campuzano O, Arbelo E, Iglesias
A, Batlle M, Pérez-Villa F, Brugada J, Pérez GJ, Scornik FS and
Brugada R: A missense mutation in the sodium channel β1b subunit
reveals SCN1B as a susceptibility gene underlying long QT syndrome.
Heart Rhythm. 11:1202–1209. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bezzina CR, Barc J, Mizusawa Y, Remme CA,
Gourraud JB, Simonet F, Verkerk AO, Schwartz PJ, Crotti L, Dagradi
F, et al: Common variants at SCN5A-SCN10A and HEY2 are associated
with Brugada syndrome, a rare disease with high risk of sudden
cardiac death. Nat Genet. 45:1044–1049. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Blich M, Efrati E, Marai I, Suleiman M,
Gepstein L and Boulous M: Novel Clinical Manifestation of the Known
SCN5A D1790G Mutation. Cardiology. 132:228–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ilkhanoff L, Arking DE, Lemaitre RN,
Alonso A, Chen LY, Durda P, Hesselson SE, Kerr KF, Magnani JW,
Marcus GM, et al: A common SCN5A variant is associated with PR
interval and atrial fibrillation among African Americans. J
Cardiovasc Electrophysiol. 25:1150–1157. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Mann SA, Castro ML, Ohanian M, Guo G,
Zodgekar P, Sheu A, Stockhammer K, Thompson T, Playford D, Subbiah
R, et al: R222Q SCN5A mutation is associated with reversible
ventricular ectopy and dilated cardiomyopathy. J Am Coll Cardiol.
60:1566–1573. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Hothi SS, Ara F and Timperley J: p.Y1449C
SCN5A mutation associated with overlap disorder comprising
conduction disease, Brugada syndrome, and atrial flutter. J
Cardiovasc Electrophysiol. 26:93–97. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Yu R, Liu L, Chen C and Shen JM: Exome
Sequencing Identifies a Novel DES Mutation (R227C) in a Chinese
Dilated Cardiomyopathy Family. Cardiology. 137:78–82. 2017.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Adsit GS, Vaidyanathan R, Galler CM, Kyle
JW and Makielski JC: Channelopathies from mutations in the cardiac
sodium channel protein complex. J Mol Cell Cardiol. 61:34–43. 2013.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Amin AS, Asghari-Roodsari A and Tan HL:
Cardiac sodium channelopathies. Pflugers Arch. 460:223–237. 2010.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Shy D, Gillet L and Abriel H: Cardiac
sodium channel NaV1.5 distribution in myocytes via interacting
proteins: The multiple pool model. Biochim Biophys Acta.
1833:886–894. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
van Hoorn F, Campian ME, Spijkerboer A,
Blom MT, Planken RN, van Rossum AC, de Bakker JM, Wilde AA,
Groenink M and Tan HL: SCN5A mutations in Brugada syndrome are
associated with increased cardiac dimensions and reduced
contractility. PLoS One. 7:e420372012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Smits JP, Eckardt L, Probst V, Bezzina CR,
Schott JJ, Remme CA, Haverkamp W, Breithardt G, Escande D,
Schulze-Bahr E, et al: Genotype-phenotype relationship in Brugada
syndrome: Electrocardiographic features differentiate SCN5A-related
patients from non-SCN5A-related patients. J Am Coll Cardiol.
40:350–356. 2002. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kapplinger JD, Tester DJ, Alders M, Benito
B, Berthet M, Brugada J, Brugada P, Fressart V, Guerchicoff A,
Harris-Kerr C, et al: An international compendium of mutations in
the SCN5A-encoded cardiac sodium channel in patients referred for
Brugada syndrome genetic testing. Heart Rhythm. 7:33–46. 2010.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Vatta M, Dumaine R, Varghese G, Richard
TA, Shimizu W, Aihara N, Nademanee K, Brugada R, Brugada J,
Veerakul G, et al: Genetic and biophysical basis of sudden
unexplained nocturnal death syndrome (SUNDS), a disease allelic to
Brugada syndrome. Hum Mol Genet. 11:337–345. 2002. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hofman-Bang J, Behr ER, Hedley P,
Tfelt-Hansen J, Kanters JK, Haunsøe S, McKenna WJ and Christiansen
M: High-efficiency multiplex capillary electrophoresis single
strand conformation polymorphism (multi-CE-SSCP) mutation screening
of SCN5A: A rapid genetic approach to cardiac arrhythmia. Clin
Genet. 69:504–511. 2006. View Article : Google Scholar : PubMed/NCBI
|